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Activation of SIRT1, an NAD+-dependent deacetylase, prevents retinal ganglion cell (RGC)
loss in optic neuritis, an inflammatory demyelinating optic nerve disease. While SIRT1
deacetylates numerous protein targets, downstream mechanisms of SIRT1 activation
mediating this neuroprotective effect are unknown. SIRT1 increases mitochondrial
function and reduces oxidative stress in muscle and other cells, and oxidative stress
occurs in neuronal degeneration. We examined whether SIRT1 activators reduce oxidative
stress and promote mitochondrial function in neuronal cells. Oxidative stress, marked
by reactive oxygen species (ROS) accumulation, was induced in RGC-5 cells by serum
deprivation, or addition of doxorubicin or hydrogen peroxide, and resulted in significant cell
loss. SIRT1 activators resveratrol (RSV) and SRTAW04 reduced ROS levels and promoted
cell survival in RGC-5 cells as well as primary RGC cultures. Effects were blocked by
SIRT1 siRNA. SIRT1 activators also increased expression of succinate dehydrogenase
(SDH), a mitochondrial enzyme, and promoted deacetylation of PGC-1α, a co-enzyme
involved in mitochondrial function. Results show SIRT1 activators prevent cell loss
by reducing oxidative stress and promoting mitochondrial function in a neuronal cell
line. Results suggest SIRT1 activators can mediate neuroprotective effects during optic
neuritis by these mechanisms, and they have the potential to preserve neurons in other
neurodegenerative diseases that involve oxidative stress.
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INTRODUCTION
Optic neuritis is an inflammatory demyelinating optic nerve
condition that often occurs in multiple sclerosis (MS) patients
(Arnold, 2005). Axonal loss also occurs in optic neuritis patients
and correlates with decreased vision (Trip et al., 2005; Fisher et al.,
2006). Significant loss of retinal ganglion cells (RGCs), the neu-
rons that comprise the optic nerve, occurs in experimental models
of optic neuritis (Guan et al., 2006; Shindler et al., 2006; Quinn
et al., 2011), providing useful models of neuronal degeneration
in demyelinating disease of the central nervous system. Recent
studies demonstrated that RGC and optic nerve injury are accom-
panied by increased reactive oxygen species (ROS) (Lieven et al.,
2006), predominantly inmitochondria, the primary source of cel-
lular ROS production and detoxification (Andreyev et al., 2005).
Increased ROS is linked to neurodegenerative diseases (Kalman
and Leist, 2003), including optic neuropathies (Qi et al., 2003,
2007). Although ROS are key mediators of CNS injury in MS and
its animal models (Cowden et al., 1998; Mohamed et al., 2003),
contributions of mitochondria to ROS activity and cell death are
not well understood.
SIRT1 is a member of the sirtuin gene family encoding
NAD+-dependent deacetylases that deacetylate histones and pro-
long survival (Imai et al., 2000; Baur et al., 2006). Sirtuins
deacetylate numerous protein targets involved in various cellu-
lar pathways, including stress responses, apoptosis, and axonal
degeneration (Yang and Sauve, 2006). Sirtuin activators and
inhibitors modulate SIRT1 activity by altering the Km for its sub-
strates (Baur, 2010). We previously showed three distinct SIRT1
activators attenuate RGC loss induced by experimental optic neu-
ritis (Shindler et al., 2007, 2010; Fonseca-Kelly et al., 2012). The
mechanism of this neuroprotection is not fully understood, but
is dependent on SIRT1, as SIRT1 inhibitors block the protec-
tive effects, and the mechanism does not involve suppression of
inflammation, suggesting other pathways must be involved.
Resveratrol (RSV) is a phytoalexin present in numerous plants
(Dong, 2003). RSV has multiple protective effects including car-
dioprotection (Chu et al., 2011), antiaging (De la Lastra and
Villegas, 2005), and defense against metabolic and neurodegen-
erative diseases (Pallàs et al., 2009). RSV improves mitochondrial
function and protects against metabolic disease by activating
SIRT1 to deacetylate the mitochondrial co-enzyme PGC-1α
(Lagouge et al., 2006). In addition, RSV exhibits antioxidant
activities (Sun and Spranger, 2005), ROS scavenging (Burkitt
and Duncan, 2000), and regulates antioxidase expression (Murias
et al., 2005). RSV affects different metabolic pathways depend-
ing on cell type, cell state, and duration and dosage of treatment.
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At the same time, RSV has numerous intracellular targets includ-
ing transcription factors/cofactors, thus regulating metabolic
homeostasis and resulting in multiple pleiotropic effects (Barger
et al., 2008; Wang et al., 2009).
Therefore, it is important to determine specific signaling path-
ways that RSV and other SIRT1 activators promote in neurons,
to better understand mechanisms of their neuroprotective effects.
Unfortunately, no specific RGC cell line exists. In the present
study, the ability of SIRT1 activators to prevent cell death induced
by oxidative stress was evaluated using RGC-5 cells. While the
RGC-5 cell line was originally reported to be a transformed rat
cell line with features of RGCs (Krishnamoorthy et al., 2001), it
has since been recharacterized (Van Bergen et al., 2009), demon-
strating features of mouse photoreceptors. RGC-5 cells retain
some characteristics of neurons, including differentiation into
neuronal-like cells with neurite outgrowth induced by treatment
with staurosporine (Frassetto et al., 2006; Wood et al., 2010). The
ability of two SIRT1 activators, RSV and SRTAW04, to promote
SIRT1 activity, reduce ROS accumulation, and increase mark-
ers of mitochondrial function was assessed in RGC-5 cells, and
because of the limits of the RGC-5 cell line, key effects were also
examined in primary RGCs isolated from neonatal mice.
MATERIALS AND METHODS
MICE
Six-week-old female SJL/J mice were purchased from the Jackson
Laboratory (Bar Harbor, ME) for induction of experimental
optic neuritis. For isolation of primary retinal cells, 3–5-day-
old C57/Bl6 mouse pups were removed from litters of timed-
pregnant mice (Jackson). Treatment of animals was reviewed and
approved by the Institutional Animal Care and Use Committee at
the University of Pennsylvania.
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE)
EAE was induced as previously described (Shindler et al., 2006).
Briefly, eight-week-old female SJL/J mice were anesthetized with
ketamine/xylazine and were injected subcutaneously at two sites
on the back with 0.1mL solution containing 0.5mg/mL pro-
teolipid protein peptide 139–151 (GenScript, Piscataway, NJ)
emulsified in complete Freund adjuvant (CFA; Difco, Detroit,
MI) containing 2.5mg/mL Mycobacterium tuberculosis (Difco).
Control mice were injected with equal volumes of PBS and CFA.
All mice were injected with 200 ng pertussis toxin (List Biological,
Campbell, CA) in 0.1mL PBS intraperitoneally on day 0 (day of
immunization) and again on day 2.
RGC-5 CULTURE AND VIABILITY
Cultures of RGC-5 cells (ATCC, Manassas, VA) were maintained
in growth medium containing low-glucose Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal bovine serum,
100U/mL penicillin, and 100μg/mL streptomycin (Sigma-
Aldrich, St. Louis, MO) in a humidified atmosphere of 95% air
and 5% CO2 at 37◦C, as described by Krishnamoorthy et al.
(2001). Cells were passaged every 3–4 days, with a doubling time
of 18–20 h. During each experiment, cells were plated at a con-
centration of 1 × 105 cells/mL and after 16 h treated with various
concentrations of RSV (Sigma-Aldrich) or SRTAW04 (Sirtris, a
GSK company, Cambridge, MA) dissolved in DMSO with or
without H2O2 for 24 h. To obtain staurosporine-differentiated
RGC-5 cells, cells were exposed to 1μM staurosporine (Cayman
Chemical, Ann Arbor, MI) for 6 h, washed three times with PBS
and then recovered in culture medium for 1 day. Control cells
were treated with DMSO only. DMSO concentration in each well
was below 0.5% v/v. For doxorubicin experiments, cells were
plated at 1 × 105 cells/mL and after 16 h treated with 1μM of
doxorubicin (Sigma, St. Louis, MO) for another 24 h. For serum
starvation experiments, media were replaced with serum free
media and cells were grown for 24 h. Cell viability was mea-
sured by trypan blue staining and counted on a hemocytometer.
Alternatively, cell viability was assessed using PrestoBlue™ Cell
Viability Reagent (Invitrogen, Grand Island, NY). Twenty-two
microliter was added to each well and incubated for 20min, and
fluorescence was read on a plate reader excited at 570 nm with
non-conjugated light emissions collected at 610 nm.
PRIMARY RGCs
The retina was removed from 3- to 5-day old C57/Bl6 mice and
cells were dissociated as described previously for neonatal rat
retina (Heng et al., 1999). Briefly, retinas were dissociated in solu-
tion containing 0.45U papain (Worthington, Lakewood, NJ) for
30min at 37◦C. After digestion, the retinal tissue was rinsed twice
with DMEM before being transferred into Neurobasal medium
containing 1% BSA (Sigma) B27-supplement (1:50, Gibco) and
penicillin/streptomycin (Gibco). Then, tissue was triturated and
passed through a cell strainer before seeding of the isolated cells
onto poly-D-lysine (0.1mg/ml, molecular weight <300,000 Da,
Sigma) and laminin (20μg/ml, Sigma) coated chamber slides. To
quantify RGC survival, chamber slides were washed twice with
PBS and fixed in 4% paraformaldehyde for 15min. Fixed cells
were permeabilized using 0.3% Triton X-100 and blocked with
1% BSA in PBS for 1 h followed by incubation with anti Brn3a
antibody (Santa Cruz biotechnology, Santa Cruz, CA) over night
at 4◦C. After washing with PBS, fluorescence-labeled secondary
antibodies (Invitrogen) were applied for 1 h at room temperature
(RT). Finally, cells were embedded in mounting medium con-
taining DAPI (Vector labs, Burlingame, CA), pictures were taken
using a fluorescence microscope (Eclipse E600; Nikon, Tokyo,
Japan), at 10× magnification and the Brn3a specific RGCs were
counted by a masked investigator.
MitoSOX STAINING
MitoSOX Red (Invitrogen) mitochondrial superoxide indicator
is a fluorogenic dye for selective detection of superoxide in the
mitochondria of live cells. For RGC-5 cultures, MitoSOX reagent
was diluted to a final concentration of 3μM in warm DMEM 1%
FBS and added to the cells. After 15min incubation at 37◦C, cells
were fixed with 4% paraformaldehyde for 10min, mounted onto
glass slides with Mowiol mounting medium, and observed under
a Eclipse E600 (Nikon, Tokyo, Japan) fluorescence microscope
using excitation 510 nm/emission 580 nm. For optic nerves, mice
were anesthetized with ketamine/xylazine and the optic nerves
were removed, washed with PBS and incubated in 5μMMitoSOX
Red for 30min at 37◦C. After incubation, nerves were washed
three times with PBS and mounted in OCT. Five micromole
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cross-sections were made, viewed by fluorescent microscopy, and
photographed at 20× magnification. One photograph centered
within each optic nerve cross section was taken by a blinded inves-
tigator using a standard exposure, and staining was quantified by
calculating the optical density using Image J software (nih.gov).
WESTERN BLOT
Cell cultures were washed twice with PBS, trypsinized for 5min,
diluted with 10× volume of PBS and centrifuged at 2000g
for 10min. Pellets were lysed in RIPA buffer (150mM NaCl,
1% NP-40, 0.5% desoxycholic acid, 0.1% SDS and 50mM Tris,
pH 8) to obtain total protein, and protein content was measured
with the BCA protein assay kit (Thermo scientific, Rockford,
IL). Proteins (30μg) were separated by polyacrylamide gel elec-
trophoresis using 10% SDS–polyacrylamide gels under reducing
conditions, then transferred with semidry blotting (Bio-Rad,
Hercules, CA) to Nitrocellulose High bound ECL membranes
(GE Healthcare Biosciences, Pittsburgh, PA). Membranes were
blocked with Odyssey Blocking Buffer (Licor Biotechnology,
Lincoln, NE) for 1 h at RT. Rabbit polyclonal antibodies against
SIRT1 (AbCam, Cambridge, MA) were used at a 1:1500 dilu-
tion overnight at 4◦C. As secondary antibody, IRDye® 800CW
Goat anti-rabbit IgG (Licor) was incubated at a 1:5000 dilu-
tion for 1 h at RT. Rabbit polyclonal SOD2 (GeneTex, Irvine,
CA) and mouse monoclonal succinate dehydrogenase b (SDHb)
(Abcam, Cambridge, MA) antibodies were used at 1:1000 dilu-
tions. As secondary antibody, IRDye® 800CW goat anti-rabbit
IgG and IRDye® 600 goat anti-mouse IgG were used at a dilu-
tion of 1:5000. Fluorescence was visualized using Odyssey infrared
imaging system (Licor). For normalization of signals, blotted
membranes were stained for β-actin (Sigma). The intensity of
each band was determined using Image J software (nih.gov).
DETECTION OF PGC-1α ACETYLATION
PGC-1α was immunoprecipitated from cell extract (500μg of
nuclear protein) using anti-PGC-1α antibody (Santa Cruz).
Immunoprecipitated PGC-1α was electrophoresed in SDS-PAGE
and immunoblotted with antibody specific for acetylated lysine
(Cell Signaling Technology, Boston, MA) to detect acetylation, or
antibody specific for PGC-1α (Novus Biologicals, Littleton, CO)
to detect total PGC-1α levels.
JC-1 STAINING OF MITOCHONDRIAL MEMBRANE POTENTIAL
JC-1 (Immunochemistry Technologies, Bloomington, MN) stain-
ing was performed according to manufacturer’s instructions
to assess mitochondrial membrane potential (Cossarizza et al.,
1993). In healthy cells due to higher mitochondrial membrane
potentials, JC-1 forms fluorescent “J aggregates” that appear red.
However, JC-1 exists as a monomer at low mitochondrial mem-
brane potential, as seen in apoptotic cells, and appears green.
Thus, the emission of this cyanin dye can be used as a mea-
sure of mitochondrial membrane potential. A stock solution of
JC-1 was prepared at 4mg/mL in dimethylsulfoxide (DMSO).
The stock JC-1 solution was added drop-wise, while vortexing,
to control medium to a final concentration of 10μg/mL. The
diluted JC-1 solution was then passed through a 0.2-μM syringe
filter (GeneMate, Kaysville, UT) and added to RGC-5 cultures
for 15min at 37◦C. After incubation, staining solutions were
decanted, each dish was washed three times with Ringer’s buffer
[in mM; 130NaCl, 5 KCl, 2 CaCl2.2H2O, 1MgSO4, 8NaOH,
1NaPO4, 5.5 D-glucose (pH 7.4)] at 37◦C, and cells were left
in fresh Ringer’s buffer. Live cell images were acquired using the
Argon laser on a fluorescent microscope (Eclipse E600; Nikon).
JC-1 was excited at 488 nm and non-conjugated light emissions
were collected at 530 nm (green) and conjugated at 590 nm (red).
The level of JC-1 staining was quantified by photographing cul-
tures with a standard exposure and calculating the optical density
of staining using Image J software.
TMRM STAINING OF MITOCHONDRIAL MEMBRANE POTENTIAL
TMRM (Immunochemistry Technologies, Bloomington, MN)
staining was performed according to manufacturer’s instructions.
Differentiated RGC-5 cells after treatment were incubated with
100 nM of TMRM for 15min and washed twice with wash-
ing buffer. Live cell images were acquired using the fluorescent
microscope (Eclipse E600; Nikon). The level of TMRM staining
was quantified by photographing cultures with a standard expo-
sure and calculating the optical density of staining using Image
J software.
SIRT1 INHIBITION WITH siRNA
SIRT1-specific siRNA, and control siRNAwere Silencer select pre-
designed siRNAs from Life Technologies (Invitrogen) and experi-
ments were performed according to manufacturer’s instructions.
Briefly, mouse primary retinal cells or differentiated RGC-5 cells
were treated with 25 nm of either SIRT1 specific siRNA or con-
trol siRNA using lipofectamine RNA iMAX transfection reagent.
24 h later, the cells were treated with H2O2 with or without drug
treatment and cell survival was assessed 48 h after transfection.
STATISTICS
Data are expressed as means ± SEM. For cell viability, SIRT1
activity, and western blot analysis, differences between cul-
ture groups were assessed using One-Way ANOVA followed by
Student Neuman–Keuls post-hoc test. Statistical differences were
considered significant at P < 0.05.
RESULTS
ROS ACCUMULATE IN OPTIC NEURITIS AND INDUCE TOXICITY
IN RGC-5 CELLS
MitoSOX Red detection of superoxide within mitochondria was
used to confirm prior studies suggesting a role of ROS accumula-
tion in optic neuritis (Qi et al., 2007) in mice with EAE, a model
of MS. EAE was induced in female SJL/J mice by immunization
with proteolipid protein peptide, andmice were sacrificed 11 days
later, when optic nerve inflammation is known to peak (Shindler
et al., 2006, 2008). Ten optic nerves of 5 EAE mice and 5 control
mouse optic nerves were isolated and incubated with MitoSOX
Red. Fluorescent microscopy of cryosectioned EAE specimens
revealed an increase in the superoxide anion compared to control
optic nerves (Figure 1).
MitoSOX staining was used to determine whether cultured
RGC-5 cells demonstrate similar superoxide accumulation in
mitochondria in response to various stressors, as seen in RGCs
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FIGURE 1 | ROS accumulate in the optic nerve during EAE. Eight-week-old
female SJL mice were immunized with proteolipid protein and were sacrificed
11 days later. Optic nerves of EAE and control mice were isolated and stained
with MitoSOX Red. (A) Cross-sections show high levels of MitoSOX Red
staining, a marker of superoxide anion, throughout the parenchyma of EAE
optic nerves, with significantly less staining in control optic nerves. One
representative nerve from a control mouse, and one EAE optic nerve, is
shown at 10× original magnification (top) and 40× original magnification
(bottom). (B) The average intensity of MitoSOX staining is significantly higher
in EAE optic nerves as compared to control optic nerves (∗p < 0.05).
axons in EAE optic neuritis. Cell viability was also measured.
RGC-5 cells were plated and incubated for 16 h prior to being
stressed by removal of serum, or by addition of doxorubicin
or hydrogen peroxide. Serum starvation of the RGC-5 cells
showed a significant decrease in cell viability by 16 h after serum
removal, with an associated increase in MitoSOX Red staining
(Figures 2A,B). Treatment with 1μM doxorubicin induced a sig-
nificant decrease in RGC-5 cells compared to control cultures,
beginning within 6 h of incubation, also with a robust increase
in the superoxide staining (Figures 2C,D), and similar RGC-5
cell loss and ROS accumulation occurred in cultures treated with
500μM hydrogen peroxide (Figures 2E,F).
Because RGC-5 cells are a transformed, dividing cell line,
we next pretreated RGC-5 cells with staurosporine (1μM for
6 h), which drives neuronal differentiation with sprouting of neu-
rites (Frassetto et al., 2006) (Figure 3A). Serum withdrawal and
doxorubicin induce cell loss and ROS accumulation in differ-
entiated RGC-5 cells (data not shown) as in undifferentiated
cells (Figure 2). We also directly introduced oxidative stress by
treating with hydrogen peroxide and found a dose dependent
loss of differentiated RGC-5 cells (Figure 3B). We used hydrogen
peroxide (500μM) for subsequent experiments to directly drive
oxidative stress.
SRTAW04 AND RSV ATTENUATE NEURONAL CELL DEATH
Previous studies showed SIRT1 activators significantly attenuate
RGC loss in experimental optic neuritis (Shindler et al., 2007,
2010; Fonseca-Kelly et al., 2012), althoughmolecularmechanisms
of effects on neuronal survival are not well understood. We inves-
tigated whether similar effects can be reproduced in neuronal
cultures. RGC-5 cells were differentiated by 1μM staurosporine
for 6 h and then grown in media with 10% serum for 24 h. After
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FIGURE 2 | Cell viability and MitoSOX staining in cultured RGC-5
cells in response to stressors. (A) RGC-5 cells were plated in
serum-containing medium for 16 h and then stressed by serum starvation
of RGC-5 cells for the next 48 h. A significant decrease in numbers
of viable cells, counted by trypan blue exclusion, (∗p < 0.05) occurs by
24 h after serum removal. (B) There is an associated increase in the
number of MitoSOX Red staining cells in serum-deprived cultures as
compared to serum-containing cultures. (C) RGC-5 cells were plated in
serum-containing medium for 16 h and then treated with 1μM
doxorubicin for 24 h. Cell viability was assessed by trypan blue exclusion.
Doxorubicin induces a significant decrease (∗∗∗p < 0.001) in RGC-5 cell
number compared to control cultures, beginning within 6 h of incubation.
(D) Increased superoxide staining is observed in doxorubicin treated
RGC-5 cultures. (E) RGC-5 cells were plated in serum-containing medium
for 16 h, then treated with 500μM H2O2 for 24 h. Cell viability was
assessed using PrestoBlue™ Cell Viability Reagent. A significant decrease
in cell viability (∗p < 0.05;∗∗∗ p < 0.001) occurs after H2O2 treatment. (F)
H2O2 induces an increase in MitoSOX staining.
24 h, cells were observed for their morphological features. Their
somas became rounder and neurites gradually increased, similar
to prior studies (Frassetto et al., 2006). The cells contacted each
other with multiple long neurites, features of neuronal differenti-
ation (Figure 3A). Differentiated cells were then pretreated with
SIRT1 activating compounds, 0.25μM RSV or 5μM SRTAW04,
for 30min before addition of 500μM H2O2. Treatment with
both SRTAW04 and RSV showed significant reduction of RGC-5
cell death compared to untreated cells, 24 h after H2O2 addition;
treatment with a known SIRT1 inhibitor (Baur, 2010), nicoti-
namide (NAM; 200μM), attenuated this protective effect whereas
NAM treatment alone did not alter cell viability (Figure 3C). We
also evaluated effects of higher RSV and SRTAW04 concentra-
tions on cell survival, but found no increased benefit of RSV at
concentrations higher than 0.25μM, nor SRTAW04 higher than
5μM (data not shown).
SRTAW04 AND RSV REDUCE ROS IN RGC-5 CELLS
To investigate whether RSV and SRTAW04 attenuate superoxide
accumulation produced by hydrogen peroxide treatment, RGC-
5 cells were pretreated with 0.25μM RSV or 5μM SRTAW04,
as used for the cell viability experiments. Cells were stained
with MitoSOX Red 24 h after exposure to 500μM H2O2,
and experiments were repeated using both differentiated and
non-differentiated RGC-5 cells. MitoSOX staining in differen-
tiated cells showed that H2O2 treatment induces an increase
in MitoSOX staining which is attenuated by both RSV and
SRTAW04, and non-differentiated RGC-5 cells showed the same
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FIGURE 3 | H2O2-induced loss of neuronal differentiated RGC-5 cells
attenuated by SIRT1 activators. (A) RGC-5 cells were plated in
serum-containing medium for 16 h and then differentiated into
neurite-sprouting neuronal cells by addition of 1μM staurosporine for 6 h.
Phase-contrast photographs demonstrate morphologic changes, including
presence of neurites, in differentiated cells. (B) Twenty-four hours
treatment of differentiated RGC-5 cells with varying doses of H2O2 shows
a significant dose dependent decrease in cell viability (∗p < 0.05 for
300μM H2O2 vs. control; ∗∗∗p < 0.001 for 500μM H2O2 vs. control;
∗∗∗p < 0.001 for 700μM H2O2 vs. control) as measured by PrestoBlue Cell
Viability Reagent. (C) Pretreatment with 0.25μM RSV or 5μM of SRTAW04
beginning 30min before H2O2 treatment, and continuing through 24 h
exposure to 500μM H2O2, shows a significant attenuation of RGC-5 death
as compared to cells exposed to H2O2 alone (∗p < 0.05; ∗∗p < 0.01). The
ability of RSV and SRTAW04 to attenuate RGC-5 cell death is blocked by
addition of SIRT1 inhibitor NAM (200μM). NAM alone does not alter cell
viability.
effect (Figure 4A). Quantification of the intensity of MitoSOX
staining in differentiated RGC-5 cells shows that this effect is sig-
nificant (Figure 4B). Untreated differentiated cells showed a small
increase in MitoSOX Red staining compared to untreated non-
differentiated cells, suggesting some effect from staurosporine
treatment itself.
SRTAW04 AND RSV ATTENUATE H2O2-INDUCED LOSS OF
MITOCHONDRIAL MEMBRANE POTENTIAL
To determine whether H2O2 treatment results in loss of mito-
chondrial membrane potential, and how this is affected by
SIRT1 activator treatment, JC-1 staining was used. Staurosporine-
differentiated RGC-5 cells were treated for 24 h with 500μM
H2O2 with or without 0.25μM RSV or 5μM SRTAW04, and
live cell fluorescent microscopy pictures were taken after JC-1
staining. Results reveal minimal remaining red fluorescent label-
ing of viable, high membrane potential mitochondria in H2O2-
treated cells as compared with healthy control cells (Figure 5).
Furthermore, the ratio of green to red fluorescent JC-1 stain-
ing showed a significant increase in H2O2-treated cells compared
with control cells. The green to red ratio was significantly lower in
H2O2-treated cells that were also treated with RSV or SRTAW04,
as compared to H2O2-treated cells without SIRT1 activators.
Results indicate that H2O2 treatment disrupts the mitochondrial
membrane potential, and this is prevented by treatment with RSV
and SRTAW04. While JC-1 stain can be used to mark mitochon-
drial membrane potential, cell membrane potential may also be
detected. Therefore, additional mitochondrial membrane poten-
tial detection was performed by staining with TMRM. Results
further suggest that H2O2 treatment disrupts the mitochondrial
membrane potential, and treatment with RSV and SRTAW04
prevents this (Figure 5).
RSV AND SRTAW04 REQUIRE SIRT1 ACTIVITY TO PREVENT
RGC-5 CELL LOSS
To confirm whether the ability of RSV and SRTAW04 to prevent
loss of RGC-5 cells is dependent on SIRT1 activity, RGC-5 cells
were transfected with SIRT1 siRNA or a control siRNA 24 h prior
to addition of 500μM H2O2 with or without RSV or SRTAW04.
RGC-5 cell numbers were quantified 24 h later. SIRT1 siRNA
blocked the ability of RSV and SRTAW04 to prevent RGC-5 cell
loss (Figure 6A), whereas control siRNA did not (Figure 6B).
SIRT1 protein expression was also measured by Western blot-
ting of extracts from cultures treated with RSV. Results show
H2O2 treatment leads to decreased SIRT1 expression, while RSV
treatment significantly limits this decrease (Figure 6C).
EFFECTS OF SIRT1 ACTIVATORS ON EXPRESSION OF MARKERS OF
MITOCHONDRIAL AND ANTI-OXIDANT FUNCTION
RGC-5 cells differentiated with staurosporine were stressed with
500μM H2O2 for 24 h, with or without addition of 0.25μM
RSV, then protein extracts were generated for Western blot-
ting. SDH functions not only in mitochondrial energy gener-
ation, but also has a role in oxygen sensing (Baysal, 2006).
Protein levels of SDH show a significant decrease during H2O2
treatment which is attenuated by RSV (Figure 7A). We also
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FIGURE 4 | SRTAW04 and RSV attenuate ROS in RGC-5 cells. RGC-5
cells were grown for 24 h with or without (control) 500μM H2O2, and
treated continuously with 0.25μM RSV or 5μM SRTAW04 where
indicated, beginning 30min before addition of H2O2. Cells were stained
with MitoSOX Red to assess ROS accumulation. (A) Significant attenuation
of MitoSOX staining is shown in representative cultures treated with RSV
and SRTAW04 compared to untreated H2O2-containing cultures for both
non-differentiated (top) and differentiated (bottom) RGC-5 cells. (B) The
average intensity of MitoSOX staining is significantly higher in H2O2
cultures as compared to control cultures (∗p < 0.05), and compared to RSV
(∗p < 0.05) and SRTAW04 (∗p < 0.05) treated cultures of differentiated
RGC-5 cells.
measured the protein expression levels of SOD2, a mitochon-
drial protein which binds to superoxide byproducts of oxida-
tive phosphorylation and converts them to hydrogen peroxide
and diatomic oxygen (Suski et al., 2012). Results show a
significant decrease in levels of SOD2 during H2O2 treat-
ment, and treatment with RSV significantly limits this decrease
(Figure 7B).
The peroxisome proliferator activated receptor (PPAR) co-
activator 1-α (PGC-1α) is a transcriptional co-activator identified
as an upstream regulator of mitochondrial number and function
(Russell et al., 2004) and is activated by SIRT1-mediated deacety-
lation (Lagouge et al., 2006). RGC-5 cell protein extracts were
immunoprecipitated with PGC-1α antibody. Western blot of the
precipitated protein was probed with either PGC-1α antibody,
or antibody to acetylated lysine, and the ratio of acetylated to
deacetylated PGC-1α was compared. Results show a significant
increase in acetylated lysine antibody immunoreactivity following
H2O2 treatment, compared to control cells, as well as compared
to RSV and SRTAW04 treated RGC-5 cells (Figure 7C). Overall
PGC-1α expression showed no significant change between culture
conditions. When compared, the decreased ratio of acetylated
lysine to PGC-1α immunoreactivity in RSV and SRTAW04
treated cells demonstrates SIRT1 activators prevent an increase in
PGC-1α acetylation.
RESVERATROL PREVENTS LOSS OF PRIMARY RGCs
While RGC-5 cells differentiated with staurosporine exhibit some
features of neurons, they are not a RGC specific cell line. Because
optic neuritis and other optic neuropathies lead specifically to
RGC loss, effects of RSV were further examined in primary
retinal cell cultures, and RGC survival was assessed. Mixed dis-
sociated retinal cells isolated from neonatal days 3 to 5 mice were
incubated overnight, transfected for 24 h with SIRT1 specific or
control siRNA, then treated for 24 h with 500μM H2O2 with or
without addition of RSV (3μM). RGCs were identified within the
mixed retinal cell cultures by immunohistochemical staining with
antibodies to Brn3a (Figure 8A), and the number of RGCs was
quantified by counting Brn3a positive cells by a blinded investi-
gator. As seen in RGC-5 cells, H2O2 induced significant loss of
primary RGCs, and RGC loss was reduced by treatment with RSV
(Figure 8B). To determine whether the mechanism of this effect
involves SIRT1 activity, primary RGC cultures were pretreated
Frontiers in Cellular Neuroscience www.frontiersin.org December 2012 | Volume 6 | Article 63 | 7
Khan et al. SIRT1 activators in neuronal cells
FIGURE 5 | SRTAW04 and RSV attenuate H2O2 induced loss of
mitochondrial potential. RGC-5 cells were plated in serum-containing
medium for 16 h and then differentiated into neuronal cells by addition of
1μM staurosporine for 6 h. Differentiated RGC-5 cells were maintained for
24 h with or without (control) 500μM H2O2, and treated with 0.25μM
RSV or 5μM SRTAW04 where indicated, beginning 30min before addition
of H2O2. JC-1 and TMRM stains were used to assess mitochondrial
membrane potential. (A) For comparison, a representative field containing
similar cell numbers was photographed from each culture (despite overall
lower cell numbers in cultures containing H2O2 without SIRT1 activators).
Green JC-1 staining (top row) labeling all mitochondria, including those
with low membrane potential, demonstrates similar mitochondrial numbers
in each culture. Red JC-1 staining (second row) labeling of normal
mitochondria shows significant loss of membrane potential in cells
exposed to H2O2, and this is reversed by addition of RSV or SRTAW04.
Merged images of green and red JC-1 staining (third row) show a high
green to red ratio in cells exposed to H2O2, with a lower ratio following
addition of RSV or SRTAW04. Red TMRM staining (bottom row) of normal
mitochondria shows similar loss of membrane potential in cells exposed to
H2O2 that is reversed by addition of RSV or SRTAW04. (B) The average
ratio of green to red staining of JC-1 is significantly higher in H2O2
cultures as compared to control cultures (∗p < 0.05), and compared to RSV
(∗p < 0.05) and SRTAW04 (∗p < 0.05) treated cultures. (C) The average
intensity of TMRM staining is significantly lower in H2O2 cultures as
compared to control cultures (∗∗∗p < 0.001), and compared to RSV
(∗p < 0.05) and SRTAW04 (∗p < 0.05) treated cultures.
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FIGURE 6 | RSV and SRTAW04 protection of RGC-5 cells is
SIRT1-dependent. Staurosporine-differentiated RGC-5 cells were
transfected with SIRT1 siRNA (A) or a control siRNA (B) and cultured with
or without 500μM H2O2, and with or without RSV (0.25 and 3μM) or
SRTAW04 (2.5 and 5μM) as indicated. SIRT1 siRNA blocked the ability of
RSV and SRTAW04 to prevent loss of RGC-5 cells (∗∗∗p < 0.001 vs.
controls). This effect is specific to SIRT1, as RSV and SRTAW04 do prevent
H2O2-induced RGC-5 loss in cells transfected with control siRNA
(∗p < 0.05). (C) Expression of SIRT1 was measured by Western blot of
protein extracts from RSV-treated RGC-5 cultures not transfected with
siRNA. Twenty-four hours after initiation of treatment, H2O2 shows a
significant decrease of SIRT1 protein expression (∗∗∗p < 0.001), whereas
treatment with RSV significantly attenuates this decrease (∗∗p < 0.01).
FIGURE 7 | RSV treatment increases markers of mitochondrial function
in stressed RGC-5 cells. Staurosporine-differentiated RGC-5 cells were
cultured with or without 500μM H2O2, and with or without 0.25μM RSV
for 24 h. (A) Western blot analysis shows a significant decrease in SDH
expression (∗∗p < 0.01) during H2O2 treatment which is attenuated by
treatment with RSV (∗p < 0.05). (B) Western blot analysis shows similar
effects on SOD2 expression. The significant decrease (∗∗p < 0.01) during
H2O2 treatment, compared to controls, is not found in cells treated with
RSV (∗p < 0.05). (C) Protein extracts were immunoprecipitated with
anti-PGC-1α antibodies, blotted, and hybridized with anti-PGC-1α and
anti-acetylated lysine antibodies to assess the acetylation state of PGC-1α.
H2O2 treatment significantly increases the proportion of acetylated PGC-1α
(∗p < 0.05) compared to controls, and RSV and SRTAW04 treatment each
prevent this acetylation (∗p < 0.05).
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FIGURE 8 | SIRT1 activators prevent loss of primary RGCs. Retinal cells
were dissociated from neonatal mice and plated overnight prior to
transfection with siRNA for 24 h and then treated 24 h with 500μM H2O2
with or without 3μM RSV. Cells were stained with antibodies to Brn3a to
detect RGCs within mixed retinal cell cultures, and numbers of Brn3a
positive cells were counted. (A) Brn3a staining demonstrates the presence
of RGCs with neuronal morphology in these primary cultures. Original
magnification × 20 (left) and × 63 (right). (B) H2O2 induces a significant
decrease in the number of RGCs (∗∗∗p < 0.001) which is attenuated by
treatment with RSV (∗∗p < 0.01) in the presence of control siRNA. SIRT1
siRNA transfection blocks the ability of RSV to attenuate RGC loss, as cell
numbers remain significantly reduced compared to controls (∗∗∗p < 0.001).
with SIRT1 siRNA. RSV neuroprotection of RGCs was blocked
by SIRT1 siRNA but not by control siRNA (Figure 8B).
DISCUSSION
In the current studies, we demonstrated that two SIRT1 acti-
vating compounds, RSV, a naturally occurring plant polyphenol
(Siemann and Creasey, 1992; Dong, 2003), and SRTAW04, a
compound that activates SIRT1 at an order of magnitude lower
concentration, similar to other SIRT1 activators (Milne et al.,
2007), both significantly reduce loss of RGC-5 cells in response
to several different stressors. SRTAW04 is a member of the same
family and exhibits similar chemical properties of SIRT1 activa-
tion as the previously described compound 14 in studies by Dai
and colleagues (Dai et al., 2010; Dr. Robert Perni, pers. com-
munication). Results in the current study demonstrating that
SIRT1 siRNA blocks the protective effects on stressed cells are
also consistent with SRTAW04 and RSV functioning through
SIRT1 activity in RGC-5 cells. While RSV is a known activator of
SIRT1, treatment also resulted in preserved expression of SIRT1
which may explain or at least contribute to SIRT1-mediated
neuroprotection.
A common feature of RGC-5 cell loss was increased oxidative
stress, as marked by accumulation of superoxide. SIRT1 activat-
ing compounds significantly reduced the level of ROSwithin cells,
suggesting that reduction of oxidative stress is one major mech-
anism of SIRT1 activator-mediated neuroprotection. Attenuation
of RSV and SRTAW04 neuroprotective effects by a known SIRT1
inhibitor, NAM, further suggests that the mechanism of these
effects is dependent on the ability of these compounds to activate
SIRT1. Interestingly, NAM has been found to be neuroprotec-
tive in some neuronal injury models, due to its ability to inhibit
PARP1 (Liu et al., 2009). Those studies used much higher con-
centrations of NAM than in the current the studies, which may
explain why NAM alone had no effect on RGC-5 cells.
We previously showed that RSV and other SIRT1 activa-
tors reduce RGC loss in EAE models of optic neuritis (Shindler
et al., 2007, 2010; Fonseca-Kelly et al., 2012), and therefore pro-
vide an important potential therapy to prevent the neuronal
damage that leads to permanent neurologic disability in optic
neuritis and MS patients. To further elucidate the mechanism
by which SIRT1 activators are able to prevent RGC loss, in the
present study we investigated effects of two SIRT1 activating
compounds on differentiated and non-differentiated neuronal
cultures. However, while original reports suggested the RGC-5
cell line is a transformed proliferating cell line that expresses
some RGC-specific markers (Krishnamoorthy et al., 2001; Wood
et al., 2010), it is important to note that the lineage and char-
acteristics of this cell line has since been found to be different
(Van Bergen et al., 2009), with features of photoreceptors, and
limits the relevance of current results to optic nerve disease.
For most of our experiments we used differentiated RGC-5 cells
because sub-lethal treatment with staurosporine induces differ-
entiation of RGC-5 cells to a non-mitotic phenotype with neurite
outgrowth and expression of at least one neuronal ion chan-
nel (Frassetto et al., 2006), making them a better model for the
study of neuronal cell properties than non-differentiated RGC-
5 cells. Importantly, SIRT1-dependent protective effects of RSV
were also found in primary retinal cultures, suggesting that the
current findings may be indicative of RGC responses and have
the potential to translate to mechanisms active in optic nerve
diseases.
Oxidative stress plays an important role in the pathophysi-
ology of optic neuritis. Studies have demonstrated that inflam-
matory cells act as mediators of optic nerve injury by release of
ROS into the extracellular microenvironment (Guy et al., 1994),
with accumulation of ROS in RGC axons in the optic nerve
(Qi et al., 2007). Consistent with these previous studies, we found
an increase in the superoxide ROS in optic nerve sections of EAE
mice. Furthermore, we showed that different stressors, serum
starvation, doxorubicin, and H2O2, induce a similar significant
increase in ROS levels in RGC-5 cell cultures, making this a useful
model for studying mechanisms of neuronal loss and neuropro-
tection. The specific use of H2O2 in RGC-5 cell and primary RGC
cultures may be especially relevant because prior reports showed
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that H2O2 plays a major role in the pathogenesis of optic neu-
ritis (Guy et al., 1993), marked by the presence of H2O2 in optic
nerves of animals with acute EAE, and during the primary stage of
demyelination, the optic nerve head is a site of H2O2 localization
derived from sensitized inflammatory cells.
Mitochondria are the primary source of cellular ROS.
Increased ROS activity is linked to neurodegenerative diseases
that have axonal and neuronal loss as a major feature (Kalman
and Leist, 2003). In addition, SIRT1 activation has been shown
previously to promote mitochondrial biogenesis in some tissues,
including muscle (Lagouge et al., 2006). Thus, we hypothesized
that the mechanism of SIRT1 activator-mediated reduction of
oxidative stress in RGC-5 cells occurs due to promotion of mito-
chondrial function, as well as due to increased levels of enzymes
that reduce oxidative stress. Consistent with this, we found that
SIRT1 activators induce a significant increase in SOD2 in RGC-5
cells. SOD2 is a crucial scavenger for superoxide in mitochon-
dria. SOD2 converts superoxide to H2O2 and mitochondrial glu-
tathione peroxidase GPx1 catalyzes the reduction ofH2O2 to H2O
(Li et al., 2000). Increase in SOD2 expression is a downstream
target of SIRT1, and consistent with our results, previous studies
showed SIRT1-induced superoxide dismutase, which was further
enhanced by RSV, increased the resistance of C2C12 myoblasts to
oxidative stress (Tanno et al., 2010).
We also found SIRT1 activators increase SDH expression in
stressed RGC-5 cells. SDH not only plays a central role in the
Krebs cycle and the respiratory chain, but it also differs from other
mitochondrial dehydrogenases due to its unique redox proper-
ties (Balietti et al., 2009). In partnership with ubiquinone, SDH
represents a crucial antioxidant enzyme in mitochondria con-
trolling superoxide scavenging activity of the respiratory chain.
When succinate-ubiquinone activity is inhibited, electrons that
would normally transfer through the SDHB subunit to the
ubiquinone pool are instead transferred to O2 to create ROS
such as superoxide (Rustin et al., 2002). It has been suggested
that the SDHB mutation results in a complete loss of electron
transport chain complex II activity in mitochondria (Gimenez-
Roqueplo et al., 2002). As a possible protective mechanism,
we investigated the preservation of mitochondrial membrane
potential using JC-1 and TMRM staining. Oxidative stress alters
mitochondrial permeability by opening transition pores, and
collapses the mitochondrial membrane potential (Niimi et al.,
2012), a major driving force for oxidative phosphorylation. Under
chronic oxidative stress, mitochondria can be subject to irre-
versible increase in permeability of the inner mitochondrial
membrane resulting in collapse of membrane potential, and
the current data showing preserved JC-1 and TMRM staining
suggest that SIRT1 activators prevent this collapse in stressed
RGC-5 cells.
Finally, SIRT1 activation induces mitochondrial biogenesis in
various tissues (Lagouge et al., 2006; Rasbach and Schnellmann,
2008; Gurd et al., 2009). Mitochondrial biogenesis is a highly
regulated process operating through PGC-1α-dependent nuclear
respiratory factors. PGC-1α is heavily acetylated by acetyltrans-
ferase GCN5 whereas it is deacetylated by SIRT1 (Gerhart-Hines
et al., 2007). SIRT1-mediated deacetylation and activation of
PGC-1α therefore serves as an important response of the cell to
increase mitochondrial metabolism.
Together, results demonstrate that SIRT1 activation pre-
vents accumulation of ROS and cell loss, suggesting that this
is one mechanism that SIRT1 activators can use to prevent
neuronal loss. Results indicate that the mechanism of RSV
effects involve SIRT1 activity, and associated deacetylation of
PGC-1α is likely to be involved in the positive regulation of
oxidative metabolism, and co-regulates the induction of other
proteins like SDH and SOD2 that participate in the cellular
response to oxidative stress. The common mechanism of oxida-
tive stress found in many neurodegenerative processes suggests
that SIRT1 activators may exert similar anti-oxidative effects
as potential neuroprotectants in a variety of neurodegenerative
diseases.
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